123 related articles for article (PubMed ID: 914399)
1. Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
Int J Cancer; 1977 Oct; 20(4):624-31. PubMed ID: 914399
[TBL] [Abstract][Full Text] [Related]
2. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
[TBL] [Abstract][Full Text] [Related]
3. Migration inhibition by an agarose microdroplet assay: monitoring of tumor-associated antigens on a simian virus 40-induced sarcoma.
McCoy JL; Padarathsingh M; Dean JH; Henriksen O; Natori T; Law LW
J Immunol; 1977 Jul; 119(1):306-10. PubMed ID: 194982
[TBL] [Abstract][Full Text] [Related]
4. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
Burton RC; Warner NL
J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity in mice against papain-solubilized histocompatibility and tumor-specific antigens by a macrophage migration inhibition microassay.
Maurer BA; Dean JH; McCoy JL; Appella E; Law LW
J Natl Cancer Inst; 1976 May; 56(5):1075-8. PubMed ID: 186617
[TBL] [Abstract][Full Text] [Related]
7. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
Braun DP; Dray S
Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
Blasecki JW; Tevethia SS
J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunity in rats with primary brain tumors: inhibition of macrophage migration by soluble extracts of avian sarcoma virus-induced tumors.
Adams DO; Gilbert RW; Bigner DD
J Natl Cancer Inst; 1976 Jun; 56(6):1119-23. PubMed ID: 186622
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
Landolfo S; Herberman RB; Holden HT
J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to mouse adenovirus infection. Macrophage migration inhibition test.
Inada T; Uetake H
Microbiol Immunol; 1978; 22(7):391-401. PubMed ID: 213697
[TBL] [Abstract][Full Text] [Related]
12. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
Svoboda I; Măzuran R; Rabatić S; Silobrcić
Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
[TBL] [Abstract][Full Text] [Related]
13. Studies of lymphocyte stimulation by intact tumor-cell and solubilized tumor antigen.
Dean JH; McCoy JL; Lewis D; Appella E; Law LW
Int J Cancer; 1975 Sep; 16(3):465-75. PubMed ID: 51834
[TBL] [Abstract][Full Text] [Related]
14. Blocking effect of the migration-inhibition reaction by sera from immunized syngeneic mice and by sera from plasmacytoma-bearing BALB-c mice. Detection of free, circulating tumor antigen.
Poupon MF; Lespinats G; Kolb JP
J Natl Cancer Inst; 1974 Apr; 52(4):1127-34. PubMed ID: 4826584
[No Abstract] [Full Text] [Related]
15. Cell-mediated immunity directed against a syngeneic plasma cell tumor in the mouse. Detection by macrophage-migration inhibition test.
Poupon MF; Lespinats G
J Natl Cancer Inst; 1972 May; 48(5):1297-301. PubMed ID: 5030949
[No Abstract] [Full Text] [Related]
16. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. I. Methodological studies on the Winn assay.
Wang KC; Berczi I; Sehon AH
Int J Cancer; 1980 Apr; 25(4):487-92. PubMed ID: 7372372
[TBL] [Abstract][Full Text] [Related]
17. Tumor immunity to murine plasma cell tumours. Influence of responder genotype on the specificity of the immune response to plasmacytomas and T lymphomas.
Burton RC; Warner NL
Aust J Exp Biol Med Sci; 1978 Oct; 56(5):587-95. PubMed ID: 751633
[TBL] [Abstract][Full Text] [Related]
18. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
19. Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11.
Giorgi JV; Burton RC; Scott D; Warner NL
Int J Cancer; 1982 Jan; 29(1):119-26. PubMed ID: 6977499
[TBL] [Abstract][Full Text] [Related]
20. Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas.
Padarathsingh ML; McCoy JL; Dean JH; Lewis DD; Northing JW; Law LW
J Natl Cancer Inst; 1977 Jun; 58(6):1701-7. PubMed ID: 301196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
